Covered recipient · General Payments record
IGNACIO JOSE RANERO
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2020–2024
$454.23
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.32 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $42.76 | 2 |
| Novo Nordisk AS | $41.33 | 2 |
| Amgen Inc. | $37.90 | 2 |
| Lexicon Pharmaceuticals, Inc. | $24.38 | 1 |
| Lilly USA, LLC | $20.41 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.34 | 1 |
| Philips Electronics North America Corporation | $13.81 | 1 |
| SHIELD THERAPEUTICS INC | $13.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $19.09 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360670 | CMS |
| Amgen Inc. | $18.81 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117360672 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.34 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117868958 | CMS |
| Lexicon Pharmaceuticals, Inc. | $24.38 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081729809 | CMS |
| Lilly USA, LLC | $20.41 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007215 | CMS |
| Novo Nordisk Inc | $24.77 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096571488 | CMS |
| Novo Nordisk Inc | $16.56 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096672427 | CMS |
| PFIZER INC. | $18.67 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130952248 | CMS |
| PFIZER INC. | $24.09 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131762730 | CMS |
| Philips North America LLC | $13.81 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146864430 | CMS |
| SHIELD THERAPEUTICS INC | $13.39 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150121339 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.